Relationship between NAD(P)H : quinone oxidoreductase 1 (NQO1) levels in aseries of stably transfected cell lines and susceptibility to antitumor quinones
Sl. Winski et al., Relationship between NAD(P)H : quinone oxidoreductase 1 (NQO1) levels in aseries of stably transfected cell lines and susceptibility to antitumor quinones, BIOCH PHARM, 61(12), 2001, pp. 1509-1516
To investigate the importance of NAD(P)H:quinone oxidoreductase 1 (or DT-di
aphorase; NQO1) in the bioactivation of antitumor quinones, we established
a series of stably transfected cell lines derived from BE human colon adeno
carcinoma cells. BE cells have no NQO1 activity due to a genetic polymorphi
sm. The new cell lines, BE-NQ, stably express wild-type NQO1. BE-NQ7 cells
expressed the highest level of NQO1 and were more susceptible [determined b
y the thiazolyl blue (MTT) assay] to known antitumor quinones and newer cli
nical candidates. Inhibition of NQO1 by pretreatment with an irreversible i
nhibitor, ES936 [5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,
7-dione], protected BE-NQ7 cells from toxicity induced by streptonigrin, ES
921 [5-(aziridin-1-yl)-3-(hydroxymethyl)-1,2-dimethylindole-4,7-dione], and
RH1 [2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-benzoquinone]. RH1 was ev
aluated further by clonogenic assay for cytotoxic response and was more cyt
otoxic to BE-NQ7 cells than to BE cells. Cytotoxicity was abrogated by inhi
bition of NQO1 with ES936 pretreatment. Using a comet assay to evaluate DNA
cross-linking, BE-NQ7 cells demonstrated significantly higher DNA cross-li
nks than did BE cells in response to RH1 treatment. DNA cross-linking in BE
-NQ7 cells was observed at very low concentrations of RH1 (5 nM), confirmin
g that NQO1 activates RH1 to a potent cross-linking species. Further studie
s using streptonigrin, ES921, and RH1 were undertaken to analyze the relati
onship between NQO1 activity and quinone toxicity. Toxicity of these compou
nds was measured in a panel of BE-NQ cells expressing a range of NQO1 activ
ity (23-433 nmol/min/mg). Data obtained suggest a threshold for NQO1-induce
d toxicity above 23 nmol/min/mg and a sharp dose-response curve between the
no effect level of NQO1 (23 nmol/min/mg) and the maximal effect level (> 7
7 nmol/min/mg). These data provide evidence that NQO1 can bioactivate antit
umor quinones in this system and suggest that a threshold level of NQO1 act
ivity is required to initiate toxic events. (C) 2001 Elsevier Science Inc.
All rights reserved.